Bayer’s heart failure drug bound for NHS on NICE recommendation

RegulatoryapprovedKerendiaPositive

AI Analysis

Summary

Bayer's Kerendia received a NICE recommendation for NHS availability in England for patients with chronic heart failure with preserved or mildly reduced ejection fraction. This regulatory approval expands the drug's market access in the UK.

Outcome Details

NICE recommendation for NHS availability in England

Importance:6/10

Sentiment:

0.70

UK regulatoryNICEheart failuremarket access

Related Companies

$BAYRY

Read the original article

Published by Pharmaceutical Technology on July 17, 2026 10:42 AM

Read Original